



Validation of a questionnaire against clinical assessment in the diagnosis of 
asthma in schoolchildren 
 
Author’s names and institutional affiliations: 
1. Tonje Elisabeth Hansen, MD 
Division of Pediatrics, Obstetrics and Woman’s Health, Nordland Hospital, Bodø, Norway  
2. Bjørg Evjenth, MD  
Division of Pediatrics, Obstetrics and Woman’s Health, Nordland Hospital, Bodø, Norway  
3. Jan Holt MD, PhD  
a) Division of Pediatrics, Obstetrics and Woman’s Health, Nordland Hospital, Bodø, 
Norway b) Institute of Community Medicine, University of Tromsø, Tromsø, Norway 
 
Corresponding author:  
Tonje Elisabeth Hansen 
Division of Pediatrics, Obstetrics and Woman’s Health, Nordland hospital, Post box 1480, 
8092 Bodø, Norway, mailto: tonje.elisabeth.hansen@nlsh.no,  
Phone: +47 97080673, Fax: + 47 75534013 
 
Running head 
‘Validating a questionnaire for children’s asthma’ 
Key words 





Aim: A questionnaire has been used repeatedly in cross sectional studies to determine the 
prevalence of asthma, allergic rhinoconjunctivitis (AR) and eczema among schoolchildren in 
Nordland County, Norway. The current study was designed to validate the questionnaire 
against clinical assessment as the diagnostic gold standard and to investigate the extent of 
possible misclassification.  
Methods: A subsample of 801 schoolchildren of 4150, whose parents had answered a 
questionnaire covering asthma and atopic diseases, underwent a detailed clinical evaluation 
including a standardized interview, a clinical examination, skin prick tests (SPT), blood 
samples, spirometry an exercise treadmill test (EIB test) and measurement of exhaled nitrogen 
oxide (FeNO).  
Results: The questionnaire had a sensitivity of 0.96 and a specificity of 0.87 for the diagnosis 
of asthma ever compared to clinical assessment. The overall agreement (kappa) was 0.80. 
After clinical assessment the prevalence of asthma ever was adjusted from 17.6 % to 16.9 % 
(95% CI: 15.8-18.0). The most sensitive and specific questions in identifying asthmatic 
children by the questionnaire were questions asking about diagnosis ('Has the child ever had 
asthma?') rather than those covering asthma symptoms such as wheeze, shortness of breath 
and/or cough. A positive exercise test increased the posttest probability for the asthma 
diagnosis only to a minimal degree. 
Conclusion: Based on the good agreement between the questionnaire responses and the 
clinical assessments, it is concluded that the questionnaire had good validity and served as a 









In recent decades the prevalence of asthma and allergic diseases has increased substantially. 
This “asthma epidemic” has led it to become the most frequent chronic disease among 
children in developed countries (1). However, wide global variation in asthma prevalence has 
been reported (2), which entails a need for further studies. The best evidence of changes in 
disease prevalence comes from repeated studies at sufficient intervals of time using the same 
instrument in the same population (3). While no screening test is perfect, valid prevalence 
estimates require a screening test with a high sensitivity and specificity (4). Validity is the 
degree to which a measurement measures what it intends to measure. The most common 
method to validate survey instruments is to compare their results to a “gold standard” test. 
Several measurements can be used in such validation. Specifically, sensitivity is the 
proportion of subjects with "true" asthma (according to the "gold standard") and specificity is 
the proportion of subjects without asthma classified correctly by the survey instrument. In the 
absence of a standardized definition of asthma and a diagnostic ‘gold standard,’ clinical 
assessment is the closest we can get to a true diagnosis (5, 6). Retrospective symptom 
questionnaires are the most commonly used to assess the prevalence of asthma in 
epidemiological studies (3, 7). However, questions about asthma symptoms are non-specific 
and are influenced by recall, recognition and awareness (8). Another limitation is the lack of 
an exact translation of the term “wheeze” in most languages (5, 9), including the 
Scandinavian vocabularies. In some instances questions relating to diagnosis may be more 
useful than symptom-based questions, even though diagnosis itself does not constitute an  
“objective” record. Some researchers have sought to increase the diagnostic accuracy of 
childhood asthma by adding objective markers such as clinical testing of bronchial 
hyperresponsiveness (BHR). Such tests seem to add little information to what is achieved by a 
 
questionnaire alone. Even if these tests do provide objective measures, which do not change 
over time, the diagnosis of asthma may (5, 10, 11).  
 
During 1985-2008, three cross-sectional surveys have been conducted in Nordland, Norway 
to estimate the prevalence of parent reported asthma, allergic rhinoconjunctivitis (AR) and 
eczema. An identical questionnaire was used in all three surveys. The 2008 - survey included 
schoolchildren (7-14 years) from randomly selected schools in Nordland County and, to 
assess time trends, were compared to those obtained in the 1985 and 1995 surveys (12, 13) to 
assess time trends (14). 'Asthma ever' was recorded if the parent answered 'yes' to one or both 
of the key questions: Has the child ever had asthma (Question 1) and Does the pupil 
experience wheeze, periods of coughing or acute shortness of breath (asthma) due to external 
factors (Question 2)? 'Current asthma' was recorded if the affirmation applied to the last 12 
months. Of the 4150 responders (63.8% oft those invited) in the 2008 survey, 729 met the 
definition criteria of asthma ever. This corresponds to a prevalence of "asthma ever" of 17.6% 
and represents a significant increase in the lifetime prevalence of asthma over a 23 year 
period; a substantial increase (4.8% to 9.9%) in current asthma was also demonstrated (14). 
Using information from the 2008 survey, a case-control study was designed to validate the 
questionnaire and to explore associative factors for asthmatic and allergic diseases. 
Assessments of its reliability and practical usefulness were additional objectives.  
 
Patients and methods 
 
The study area 
Nordland County, Norway with a subarctic area of 38000 km2 and has a population of 
240.000. Its unique geography features a long coastline (25 % of Norway’s total), with half of 
it located north of the Arctic Circle. Thus most of Nordlands’ inhabitants live in sparsely 
populated areas and experience a coastal climate 
 
Study design  
Based on a questionnaire-based survey in 2008 parental-reported asthma symptoms and 
diagnosis in schoolchildren (7-14 years) for 729 children met the definition criteria of asthma 
ever. We invited a subsample of the 4150 children enrolled in the original cohort to 
participate in a case-control study. This follow-up study took place at four outpatient 
locations in Nordland (specifically, Bodø, Fauske, Mo and Sortland). The study locations 
were selected on the basis of capturing as many participants as possible. Children who met 
the questionnaire definition criteria of asthma ever and lived within 2 hours car the study 
locations (572/729), together with non-asthmatic controls were invited to participate (a total 
of 1144 children). Cases and controls were matched on individual basis for age and gender. A 
total of 801 children with their parents participated (70 % attendance), more controls (428) 
than cases (373). Although not pursued in the current study, the case-control method was 
chosen in order to permit a study association between the occurrence of asthma and exposure 
of potential risk factors. The current questionnaire validity study did not need to be in the 
case-control format. The participants underwent a standardized interview, a clinical 
examination and substantial clinical testing including skin pricks tests (SPT), spirometry, an 
exercise treadmill test (EIB test) and measurement of exhaled nitrogen oxide (FeNO); blood 
 
samples were also collected. All interviews and procedures were conducted by one of the two 
authors (TEH and BE), and the same medical instruments were used to secure standardized 
measurement conditions. Parents/guardians signed a written consent for their children’s 
participation. The study took place between March 2009 and July 2010, during the school 
semester.  
 
Clinical assessment  
The interview covered birth data, socio-economic conditions, health status, infections and 
asthma symptoms during the child’s first three years of life, diet, medication, secondhand 
smoke exposure and household animals. A clinical examination including height, and weight 
measurements and assessment of skin, upper airway, lung and heart was performed. The 
diagnosis was based on clinical assessment (interview including disease history and clinical 
examination) alone, not taking clinical testing or laboratory test-results into account. This 
simulated a clinical setting in a doctor's office. The asthmatic children were categorized as 
current asthmatics or not, and asthma severity was classified according to the GINA 
guidelines  (15). For assessment of the reliability of the original questionnaire, the parents 
answered a new questionnaire with the same key questions regarding asthma, AR and eczema, 
as done during the survey in 2008. The time interval between the original and current 
administration of the questionnaire was 1.5 -2 years.  
 
Definitions 
The definitions used in the case-control study were those of Lødrup Carlsen (16). Asthma 
ever: at least two of the following three criteria being fulfilled; re-current dyspnoea, chest 
tightness and/or wheezing; doctor’s diagnosis of asthma; and use of asthma medication (ß-2 
agonist, sodium cromoglycate, corticosteroids, leukotriene antagonists and/or aminophylline).  
 
Current asthma: asthma as defined above plus symptoms and/or asthma 
medication within the last year. Allergic sensitization (atopy) was defined by a 




The SPT was performed for the following allergens: birch, timothy, Cladiosporium 
herbarium, Alternaria tenius, Artemisia vulgaris (mugwort), Dermatophagoides 
pteronyssinus, cat, dog, rabbit, German cockroach, milk, egg white, peanut and cod. Total IgE 
and serum allergen-specific IgE (sIgE) to the above listed allergens were analyzed using the 
IMMULITE 2000 immunoassay (Siemens Healthcare Diagnostic Inc., Deerfield, IL, USA). 
Spirometry, EIB tests and measurements of FeNO were conducted in accordance with 
published guidelines as previously described  (17). Forced expiratory volume at 1 minute 
(FEV1) was measured at baseline and at 3, 6, 10, 15 and 20 min after the exercise, and a 
positive EIB test was defined as a decrease in FEV1 ≥10%.  
 
Statistical analyses 
Validity of the questionnaire was determined by agreement between questionnaire responses 
and clinical assessments. Agreement was measured as sensitivity and specificity. Corrected 
estimates for the prevalence of asthma ever and current asthma was calculated as the sum of 
the positive predictive values for both positive and negative questionnaire replies to asthma, 
weighted by their relative frequencies. Agreement between EIB and clinical assessment was 
assessed using post-test odds and the probability for a positive EIB tests. The test-retest 
reliability of the questionnaire was assessed using Cohen´s kappa. Corrected inter-group 
comparisons were analyzed with Pearson’s chi-square test for categorical data and 
 
independent t- test for continuous data. The distribution of FeNO values was right skewed, 
and thus analyses were executed with natural log (ln) transformed data. The results were 
presented as back-transformed values and expressed as geometric means. All tests were two-
sided using a significance level of 0.05. All analyses were made using the Statistical Package 
for Social Science (SPSS) software version 19.0 (SPSS Inc. IBM, Chicago, IL, USA). 
 
Ethical approval 
The Regional Committee for Medical and Health Research Ethics, Northern Norway and The 




Asthmatic children had higher mean body mass index (BMI) and suffered more frequently 
from eczema, AR and food allergy than non-asthmatic children (Table 1). Compared to the 
original study cohort from 2008 mean age was higher in asthmatics (12.4 versus (vs) 11.2 
years) and non-asthmatics (12.6 vs 10.9 years); and there were more boys among the non-
asthmatic children (46.8 % vs 59.8 %). More children were suffering from eczema in 
asthmatics (48.6% vs 31.4%) than in non-asthmatics (32.0 vs. 16.7) and more non-asthmatic 
were suffering from AR (26.6% vs. 19.5%). Other than these differences the two cohorts were 
similar in terms of demographic data and clinical characteristics.  
 
Validity and reliability of the questionnaire 
Of the 801 children participating, 373 had parental reported “asthma ever”. After the clinical 
assessment 64 of the designated 373 asthmatic children did not meet the asthma definition 
criteria (i.e., false positives). Of the 428 apparent non-asthmatic children, 14 met the asthma 
 
definition criteria after the clinical assessment (i.e., false negatives) (Fig. 1). Thus the survey 
questionnaire had a sensitivity of 0.96 and a specificity of 0.87. Assuming that the clinical 
assessment represents a true diagnosis of asthma (“gold standard”), the estimated prevalence 
of asthma ever in the 2008 survey was adjusted from 17.6% to 16.9% 309/373 × 729/4150 + 
14/428 × 3421/4150 = 0.169, standard error (SE) 0.006, 95%CI: 0.158-18.0. In the group of 
asthmatic children, 153 (47.4%) children fulfilled the definition criteria of current asthma. 
Similarly the prevalence of current asthma was changed from 9.9% to 10.8% (SE 0.005, 
95%CI: 9.8-11.8). Following the GINA guidelines (15), 69 children had intermittent and 84 
children had mild persistent asthma. No children were classified as moderate or severe 
persistent asthmatics.  
 
The test-retest reliability (kappa) of the asthma definition used in the 2008 survey was 0.80 
(SE 0.02); for question 1 (“Has the child ever had asthma?”) alone the agreement was 0.87 
(SE 0.02). Analyzing individual answers from the questionnaire compared to clinical 
assessment revealed differences in sensitivity and/or specificity between questions covering 
asthma symptoms and diagnosis (Table 2). 
 
The misclassified children 
Misclassified children that were transferred from the asthmatic group to non-asthmatics (false 
positive) after the clinical assessment, 21/64 (32.8%) had answered affirmatively to Question 
1 in the original questionnaire and 52/64 (83.9%) answered affirmatively to Question 2. The 
interview revealed that 25/64 (39.1%) of the children had experienced respiratory symptoms 
(wheezing, dyspnoea, cough), but not asthma during the first three years of life. In 22/25 
(88.0%) of these children the episodes of symptoms were associated with fever, colds and 
other airway infections. In the false positive group 40/64 (62.5%) had atopic disease, 36/64 
 
(56.3%) suffered from AR ever, and 28/64 (43.8%) from eczema ever. In the group of 
misclassified children that changed groups from non-asthmatic to asthmatic (n=14) after the 
clinical assessment (false negative), eight children represented new asthma cases and six 
represented under-diagnosis of self-reported "asthma ever" in the 2008 survey.  
 
Examination 
Asthmatic children were more often sensitized to allergens, had higher FeNO values and had 
more often a positive EIB test than non-asthmatics. However, spirometric values were not 
significantly different between the groups (Table 3). A positive exercise test yielded a 
sensitivity of 0.12 and a specificity of 0.92 relative to the clinical assessment. The posttest 
odds (= pretest probability/ (1-pretest probability) x LR+) and posttest probability (= posttest 




The main finding in this study was the good agreement between the questionnaire-based 
diagnosis of asthma and the clinical assessment by a doctor. This finding is in line with a 
validation of a 1995 questionnaire among schoolchildren in Southern Norway (18). For a 
questionnaire to be a useful research tool, the responses must be repeatable (minimum 
measurement error). The test-retest reliability of asthma definition by questionnaire may be 
judged substantial (19), especially considering the time interval between the survey and the 
case-control study. This, together with the good agreement supports the conclusion that the 
questionnaire is a potential useful epidemiological tool. 
 
 
Most of the misclassifications and over-diagnoses in this study were due to parent’s response 
to Question 2 in the 2008 survey. This question covered several symptoms including the 
cardinal symptom of asthma, wheeze. Reported wheeze has extensive differential diagnosis 
and parental interpretation. Conceptual understanding of wheeze may differ from that of 
physicians and from epidemiology definitions (20, 21). Interpreting symptoms of reported 
wheeze as being asthma may result in over-estimating the prevalence of childhood asthma. In 
addition the higher prevalence rates of wheeze in English speaking countries have questioned 
the validity of translating wheeze into other languages (22, 23). The clinical assessment 
revealed that parents misinterpreted their child’s symptoms associated with respiratory 
infections in early life as asthma. This finding is in line with results from a USA and 
European study among preschool children (9). In this study, 32 % of the children reported 
recurrent asthma symptoms, while only 20 % reported a doctor’s diagnosis of asthma. If one 
uses questions covering only symptoms, one risks more false positive and “over-diagnosing”. 
In our opinion the false positive children in the study may represent 'transient infantile 
wheeze' (24). Thus, in this present population, questions covering diagnosis rather than 
symptoms in the 2008 survey provided a better prediction of the asthma prevalence. Some of 
the misclassification may have been due to the large number of children suffering from AR in 
the over-diagnosed group. Symptoms of AR and asthma resemble each other, and this can 
make it difficult for parents to distinguish between the two diseases.  
 
The diagnosis of asthma is problematic as episodic symptoms and exacerbations are essential 
components of the disease. This makes the use of clinical testing as an epidemiological tool 
challenging. In agreement with other studies (4, 11, 25), the intensive examinations 
performed yielded little additional information. Spirometric values were not significantly 
different in the subgroups and posttest probability increased only to a minor degree for the 
 
EIB test. Baseline FeNO was significantly higher in asthmatic than in non-asthmatic children, 
in line with findings from other studies (26, 27). This is probably caused by a higher 
proportion of asthmatic children suffering from AR (17). Hence clinical testing, while 
essential both in the diagnosis of asthma and in clinical management of current asthma, is less 
important as an epidemiological tool. 
 
Studies validating epidemiological tools are important. The present study combines the best 
qualities of questionnaires and testing, namely, by first performing a questionnaire survey and 
subsequently conducting more intensive examinations on a large subsample of children. Since 
both symptomatic and non-symptomatic study subjects were examined, it was possible to 
estimate the extent of misclassification in the questionnaire survey. To ensure reproducibility 
the sample was large and two doctors performed all assessments and examinations. 
 
Our study has a number of limitations. First, a problem inherent to asthma questionnaires is 
that questions covering diagnosis and clinical assessment may not be truly independent of 
each other. As a diagnosis is not merely an objective record, it could include an intervention 
that may affect parental perception. Hence, it might be difficult to evaluate as to whether 
parents are just recalling previous outcomes when answering questions concerning diagnoses. 
In addition, studies have shown substantial inconsistency concerning information on 
children’s chronic health conditions (asthma) based on medical record data and parents-
reports (28, 29). The inconsistency may be due to a misunderstanding of the conditions and 
the reliability of parental reporting. This illustrates the need for caution in making definitive 
statements. Secondly, the reviewers were not blinded to the previous parental reported asthma 
status. Ideally, the reviewers should have been blinded, but this was not possible within the 
organization of the study. However, the reviewers had no knowledge about the specific 
 
answers to the individual questions in the 2008 survey. We believe that this has only 
influenced the results in a minor way. A third limitation may be that participation in asthma 
studies may be associated with more awareness of symptoms and interest which could have 
introduced a selection bias. Selection bias is best avoided by achieving a high response rate. 
The response rate in the 2008 survey was lower than desirable, as discussed in an earlier 
publication (14). Even though a high participation rate is preferable, most empiric work 
suggests that lower participation rates are not likely to have a substantial influence on the 
measures of interest (30).  
 
Conclusion  
The questionnaire used appears to be a valid proxy for clinical assessment in terms of 
identifying cases of asthma in schoolchildren. Detailed clinical testing adds little additional 
information in such diagnoses. Within the limitations of our case-control study design, 
questions covering disease predicted asthmatic children better (with higher sensitivity) than 
those covering symptoms. Thus the questionnaire might bee a good research tool for future 
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TABLE 1. Demographic data of the cases and controls in the study "Asthma and 
allergy among schoolchildren in Nordland" after clinical assessment. 
  Asthmatic Non-asthmatic P - value 
  n = 323 n = 478   
Boys* 204 (63.2) 286 (59.8) 0.343 
Girls* 119 (36.8) 192 (40.2) 0.343 
Age (years)** 12.4 (1.9) 12.6 (1.9) 0.185 
Body mass index (BMI)** 20.3 (4.2) 19.6 (3.7) 0.014 
Birth weight in (grams)** 3467 (646.3) 3537 (651.1) 0.150 
Gestation age (weeks)** 39.3 (2.5) 39.5 (2.0) 0.222 
Number of siblings** 1.9 (1.0) 2.0 (1.0) 0.309 
Fathers years in school (years)** 13.2 (2.7) 13.5 (2.7) 0.103 
Mean mothers years in school (years)** 14.0 (2.6) 14.1 (2.6) 0.529 
Secondhand smoke exposure** 116 (35.9) 143 (29.9) 0.075 
Comorbidity    
Eczema* 157 (48.6) 153 (32.0) 0.000 
Allergic rhinoconjunctivitis* 156 (48.3) 127 (26.6) 0.000 
Food allergy* 49 (15.2) 32 (6.7) 0.001 
Urticaria* 56 (17.3) 93 (19.5) 0.441 
*Results are given in exact numbers (percentages).  




TABLE 2. The agreement between parents answers to questions about asthma and asthma symptoms in the cross-sectional survey compared 
to clinical assessment in the case-control study (from the study: “Asthma and allergy among schoolchildren in Nordland” (14)). 
 
Asthmatic            
n = 323 
Non-asthmatic        
n = 478 
Sensitivity Specificity 
1. Has the pupil ever had asthma? (Question 1) 290/323 21/476  0.90 0.96 
2. Has the pupil had asthma in the past 12 months? 144/289 4//92 0.96 0.50 
3. Does the pupil experience wheeze, periods of coughing or acute  182/316  53/460  0.58 0.88 
    shortness of breathes due to external factors? (Question 2)     
4. Does the pupil experience wheeze, periods of coughing or acute shortness  142/241 39/156 0.75 0.59 
    of breath (asthma) due to external factors in the past 12 months?     
5. Has the pupil ever experienced episodes of dyspnoea? 164/303 47/441 0.54 0.89 
6. Has your child chest ever sounded wheezy during or after exercise? 139/316 21/446 0.44 0.95 
7. Has your child had ever a dry cough at night, apart from a cough  205/315 94/449 0.65 0.79 
    associated with a cold or chest infection?     
8. Has your child ever used asthma medication? 304/322  42/456  0.94 0.91 
9. Did a doctor diagnose your child with asthma? 270/318  15/456  0.85 0.97 




TABLE 3. The test results from the case-control study in "Asthma and allergy among 
schoolchildren in Nordland" (14). 
  Asthmatic Non-asthmatic P - value  
  n = 323 n = 478  
Allergic sensitization (% of total) 218 (67.5) 259 (54.2) 0.000 
Mean baseline FeNO (95%CI) 14.74 (13.38-16.24) 10.75 (10.12-11.41) 0.000 
Positive exercise test (% of total) 57/315 (18.1) 26/466 (5.6) 0.000 
Mean baseline lung function     
FEV1 (95% CI) 2.59 (2.51-2.67) 2.63 (2.56-2.69) 0.492 
FVC (95% CI) 3.00 (2.90-3.09) 3.06 (2.98-3.14) 0.273 
FEV1% (95% CI) 86.1 (85.4-86.8) 85.8 (85.3-86.4) 0.547 
FEF50 (95%CI) 3.13 (3.01-3.24) 3.15 (3.06-3.24) 0.695 




Figure 1.  
Participant flowchart for the study “Asthma and allergy among schoolchildren in Nordland” 
(14).  
